NuCana plc NCNA
Set alert
0.98 USD -0.02 -2.48%
At close
0.98 0.00 +0.07%
Pre-market · Nov 3, 7:28 AM ET
0.9801 Day range 1.04
0.948 52-week range 4.55
- YTD
- -72.78%
- 1 year
- -75.56%
- Open
- 1.02
- Prev close
- 1.01
- Mkt cap
- 4.08M
- Vol
- 38.86K
- Avg vol
- 120.53K
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.9801
- High
- 1.04
- Forward P/E
- -0.13
- Beta
- 1.04
- Short ratio
- 0.31
- Inst. own
- 11.82%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 1.50
- 200-d avg
- 3.56
- 1y target
- 64.50
3M chart
Signals (9)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Oct 26, 2026 | 1 week ago |
| SMA: Bearish | Sep 4, 2026 | 1 month ago |
| SMA: Bullish | Sep 3, 2026 | 2 months ago |
| SMA: Bearish | Sep 1, 2026 | 2 months ago |
| SMA: Bearish | Sep 1, 2026 | 2 months ago |
| MACD: Sell Signal | Sep 1, 2026 | 2 months ago |
| SMA: Bullish | Aug 14, 2026 | 2 months ago |
| SMA: Bearish | Aug 5, 2026 | 2 months ago |
| SMA: Bullish | Aug 4, 2026 | 3 months ago |
Analyst view
Consensus: none
Price target (mean) 64.50 +6481.0% upside
Now 0.9801
- Target (low)
- 25.00
- Target (mean)
- 64.50
- Target (high)
- 104.00
Ratings (0m) 3 1 buy · 2 hold · 0 sell
- Strong buy0
- Buy1
- Hold2
- Sell0
- Strong sell0
Recommendation trend
- This month 3
- 1 month ago 4
- 2 months ago 4
- 3 months ago 4
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.088 | -0.088 – -0.088 | -4.45 | +98.0% | 0 | 0.0% | 1 |
| Next quarter | -0.088 | -0.088 – -0.088 | -4.12 | +97.9% | 0 | 0.0% | 1 |
| Current year | -0.502 | -0.502 – -0.502 | -16.85 | +97.0% | 0 | 0.0% | 1 |
| Next year | -8.23 | -16.08 – -0.377 | -0.502 | -1538.7% | 0 | 0.0% | 2 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 19, 2024 | Oppenheimer | Reiterated | Outperform | Outperform |
| Jul 23, 2024 | Oppenheimer | Reiterated | Outperform | Outperform |
| Jul 22, 2024 | Oppenheimer | Maintained | Outperform | Outperform |
| Apr 1, 2024 | Oppenheimer | Reiterated | Outperform | Outperform |
| Nov 21, 2023 | Oppenheimer | Reiterated | Outperform | Outperform |
| Sep 6, 2023 | Truist Securities | Reiterated | Buy | Buy |
| Aug 18, 2023 | Oppenheimer | Reiterated | Outperform | Outperform |
| May 22, 2023 | Oppenheimer | Reiterated | Outperform | Outperform |
| Sep 22, 2022 | Jefferies | Maintained | — | Buy |
| Mar 3, 2022 | Cowen & Co. | Downgrade | Outperform | Market Perform |
| Nov 24, 2021 | HC Wainwright & Co. | Maintained | — | Buy |
| Dec 1, 2020 | HC Wainwright & Co. | Maintained | — | Buy |
| Nov 24, 2020 | HC Wainwright & Co. | Maintained | — | Buy |
| Oct 22, 2020 | Truist Securities | Initiated | — | Buy |
| Aug 21, 2020 | HC Wainwright & Co. | Maintained | — | Buy |
| Jul 24, 2020 | Oppenheimer | Initiated | — | Outperform |
| Mar 11, 2020 | HC Wainwright & Co. | Maintained | — | Buy |
| Nov 15, 2019 | HC Wainwright & Co. | Reiterated | — | Buy |
| Aug 19, 2019 | HC Wainwright & Co. | Initiated | — | Buy |
| Oct 19, 2018 | Piper Sandler | Initiated | — | Overweight |
| Oct 23, 2017 | Citigroup | Initiated | — | Buy |
| Oct 23, 2017 | Cowen & Co. | Initiated | — | Outperform |